methotrexate sodium

Drug ingredientActive Shortage

This drug ingredient is in active FDA shortage. At least one manufacturer cannot meet demand.

Molecular structure of 7413-34-5

Where It Comes From

27 FDA-registered drug labelers
A-S Medication Solutions
Accord Healthcare Inc.
Alembic Pharmaceuticals Inc.
Alembic Pharmaceuticals Limited
Aurobindo Pharma Limited
Bryant Ranch Prepack
Chartwell RX, LLC
Coupler LLC
Elite Laboratories, Inc.
Eugia US LLC
Excella GmbH & Co. KG
Fermion Oy
Fresenius Kabi USA, LLC
Golden State Medical Supply, Inc.
Hikma Pharmaceuticals USA Inc.
Hospira, Inc.
Medexus Pharma Inc.
MSN Laboratories Private Limited
Mylan Institutional Inc.
Mylan Pharmaceuticals Inc.
NuCare Pharmaceuticals, Inc.
Proficient Rx LP
Safecor Health LLC
Sun Pharmaceutical Industries, Inc.
Teva Parenteral Medicines, Inc.
Teva Pharmaceuticals USA, Inc.
Teva Women's Health, Inc.

Why It Matters

Sectors
Health
Downstream Uses

Appears in 4 drug and cosmetic product listings (FDA).

  • Methotrexate Sodium
  • Methotrexate
  • Rasuvo
  • Trexall
FDA Shortage Status
Active Shortage
Shortage History
current

Methotrexate Sodium Injection

03/13/2023

Limited Availability

current

Methotrexate Sodium Injection

03/13/2023

Available

current

Methotrexate Sodium Injection

03/13/2023

Unavailable

Chemical Identity

CAS7413-34-5
PubChem CID11329481
DTXSIDDTXSID3037123
FormulaC20H20N8Na2O5
Mol. Weight498.4 g/mol
SMILESCN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)[O-])C(=O)[O-].[Na+].[Na+]

Data Sources

113294812026-04-07

https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/name/methotrexate sodium/cids/JSON

Archive: data/sources/pubchem_name/methotrexate sodium.json

CAS 7413-34-52026-04-25

https://open.fda.gov/data/ndc/

Archive: data/sources/fda/ndc/ndc.json

CAS 7413-34-52026-06-13

https://api.fda.gov/drug/shortages.json

Archive: data/sources/fda/shortages/shortages.json